0% found this document useful (0 votes)
310 views1 page

2016-TreatmentCSE Algorithm PrintReady

The document proposes an algorithm for treating convulsive status epilepticus in three phases: stabilization, initial therapy with benzodiazepines, and second therapy with additional anticonvulsants if needed. It provides options for medications and dosages at each phase.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
310 views1 page

2016-TreatmentCSE Algorithm PrintReady

The document proposes an algorithm for treating convulsive status epilepticus in three phases: stabilization, initial therapy with benzodiazepines, and second therapy with additional anticonvulsants if needed. It provides options for medications and dosages at each phase.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Proposed Algorithm for Convulsive Status Epilepticus

From “Treatment of Convulsive Status Epilepticus in Children and Adults,” Epilepsy Currents 16.1 - Jan/Feb 2016
Interventions for emergency department, in-patient setting,
Time Line or prehospital setting with trained paramedics

1. Stabilize patient (airway, breathing, circulation, disability - neurologic exam)


2. Time seizure from its onset, monitor vital signs
3. Assess oxygenation, give oxygen via nasal cannula/mask, consider intubation if respiratory assistance
0-5 Minutes needed
Stabilization 4. Initiate ECG monitoring
Phase 5. Collect finger stick blood glucose. If glucose < 60 mg/dl then
Adults: 100 mg thiamine IV then 50 ml D50W IV
Children ≥ 2 years: 2 ml/kg D25W IV Children < 2 years: 4 ml/kg D12.5W IV
6. Attempt IV access and collect electrolytes, hematology, toxicology screen, (if appropriate) anticonvulsant
drug levels

Does Seizure
YES Continue? NO

A benzodiazepine is the initial therapy of choice (Level A): If patient at baseline,


Choose one of the following 3 equivalent first line options with dosing and frequency: then symptomatic
• Intramuscular midazolam (10 mg for > 40 kg, 5 mg for 13-40 kg, single dose, medical care
Level A) OR
5-20 Minutes • Intravenous lorazepam (0.1 mg/kg/dose, max: 4 mg/dose, may repeat dose
Initial Therapy once, Level A) OR
Phase • Intravenous diazepam (0.15-0.2 mg/kg/dose, max: 10 mg/dose, may repeat dose
once, Level A)
If none of the 3 options above are available, choose one of the following:
• Intravenous phenobarbital (15 mg/kg/dose, single dose, Level A) OR
• Rectal diazepam (0.2-0.5 mg/kg, max: 20 mg/dose, single dose, Level B) OR
• Intranasal midazolam (Level B), buccal midazolam (Level B)

Does Seizure
YES Continue? NO

There is no evidence based preferred second therapy of choice (Level U): If patient at baseline,
Choose one of the following second line options and give as a single dose then symptomatic
• Intravenous fosphenytoin (20 mg PE/kg, max: 1500 mg PE/dose, single dose, medical care
20-40 Minutes Level U) OR
Second Therapy • Intravenous valproic acid (40 mg/kg, max: 3000 mg/dose, single dose,
Phase Level B) OR
• Intravenous levetiracetam (60 mg/kg, max: 4500 mg/dose, single dose, Level U)
If none of the options above are available, choose one of the following (if not given
already)
• Intravenous phenobarbital (15 mg/kg, single dose, Level B)

Does Seizure
YES Continue? NO

40-60 Minutes There is no clear evidence to guide therapy in this phase (Level U): If patient at baseline,
Third Therapy Choices include: repeat second line therapy or anesthetic doses of either thiopental, then symptomatic
Phase midazolam, pentobarbital, or propofol (all with continuous EEG monitoring) medical care

Disclaimer: This clinical algorithm/guideline is designed to assist clinicians by providing an analytic framework for evaluating and treating
patients with status epilepticus. It is not intended to establish a community standard of care, replace a clinician’s medical judgment, or
establish a protocol for all patients. The clinical conditions contemplated by this algorithm/guideline will not fit or work with all patients.
Approaches not covered in this algorithm/guideline may be appropriate.
2016 © Epilepsy Currents

You might also like